Health in Oman

1,016 indicators covering health for Oman.

IndicatorLatest Year10-yr change Rank
Reported rabies deaths 0 2022 β€” 61st
Number of current cigarette smokers, estimate 447,000 2030 up 53.1% 105th
Incidence of malaria 0 per 1,000 population at risk 2024 β€” 79th
Reported number of children receiving antiretroviral therapy 22 2025 down 29.0% 96th
Concentrations of fine particulate matter 32.69 2023 up 0.5% 37th
Death rate road traffic injuries 10.6 2019 down 61.9% 121st
New or unknown treatment history cases: Pulmonary, bacteriologically c 439 2023 up 96.0% 124th
Cholera case fatality rate 0 2021 β€” 37th
Medical doctors not further defined 7,673 2013 up 105.9% 62nd
Life satisfaction vs life expectancy 80.03 2023 up 1.8% 57th
Estimate of current cigarette smoking prevalence 9.8% 2030 up 11.4% 100th
Estimate of current cigarette smoking prevalence (%) 7.0% 2030 up 11.1% 121st
Tb patients tested positive for hiv 4 2021 down 50.0% 131st
Number of children aged 6-59 months with anaemia 109.24 2019 up 24.8% 110th
Prevalence of anaemia in children aged 6-59 months 24.3% 2019 down 23.6% 110th
Number of deaths attributed to non-communicable diseases, by type of d 1,750 2019 up 32.1% 141st
Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 unchanged 101st
Mean hemoglobin level of children aged 6-59 months 118 2019 up 2.6% 74th
Estimated number of MDR/RR-TB incident cases 8 2024 up 14.3% 148th
Mortality caused by road traffic injury 10.6 per 100,000 population 2019 down 70.1% 122nd
Mortality caused by road traffic injury, female 4.7 per 100,000 female population 2019 down 64.9% 120th
Mortality caused by road traffic injury, male 13.6 per 100,000 male population 2019 down 73.2% 129th
Ipv vaccine coverage 99 2024 unchanged 1st
Tb patients living with hiv receiving art 4 2021 down 42.9% 115th
HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 unchanged 1st
Hospital beds 9.95 2023 down 20.9% 127th
Treatment success rate for patients treated for MDR-TB 0.0% 2022 down 100.0% 159th
New leprosy case detection rate per 1 000 000 population 0.189 2024 down 87.6% 109th
Treatment success rate: HIV-positive TB cases 57 2023 down 43.0% 121st
Prevalence of wasting, weight for height 9.3% 2017 up 31.0% 13th
Bladder cancer death rate 0.8569 2021 up 27.9% 92nd
Cancer death rates by type who db 0.8569 2021 up 27.9% 92nd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 99.0% 2025 β€” 1st
International Health Regulations core capacity scores, SPAR version, 2 40 2025 β€” 112th
Prevalence of underweight, weight for age 11.2% 2017 up 30.2% 43rd
Leprosy registered prevalence rate per 1 000 000 population 0.189 2024 down 87.6% 107th
Leprosy - Number of new leprosy cases among children 0 2024 β€” 69th
Leprosy - Number of cases registered for treatment 1 2024 down 83.3% 113th
New leprosy child case detection rate (less than 15 years of age) per 0 2024 β€” 69th
Ipv1 number unvaccinated 846.12 2023 up 5.8% 147th
Contraceptive prevalence, any method 29.7% 2014 down 6.3% 94th
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Liver cancer death rate 2.1 2021 up 31.2% 105th
Number of female leprosy new cases 0 2024 down 100.0% 102nd
Estimated number of malaria deaths 0 2024 β€” 66th
Estimated number of malaria cases 0 2024 β€” 82nd
Contraceptive prevalence, any modern method 18.8% 2014 down 23.6% 99th
National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 β€” 157th
Number of prevalent tuberculosis cases 520 2014 up 23.8% 146th
Estimated malaria incidence 0 2024 β€” 82nd
Estimated malaria mortality rate 0 2024 β€” 66th
Number of new G2D leprosy cases 0 2024 β€” 86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 β€” 86th
Pancreatic cancer death rate 1.13 2021 up 40.0% 109th
Brain and nervous system cancer death rate 0.3549 2021 down 49.8% 111th
Inflation-adjusted prices for most sold brand of cigarettes: Prices in 10.91 2022 up 79.7% 29th
Taxes as a % of price: total tax 66.0% 2022 up 197.2% 71st
Taxes as a % of price: value added tax 4.8% 2022 β€” 161st
Taxes as a % of price: ad valorem excise 48.8% 2022 β€” 14th
Taxes as a % of price: specific excise 0.0% 2022 β€” 135th